Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Regulatory explorer
Regulatory document

FDA Notice: Draft Guidance on New Dietary Ingredient Notification Master Files

A US FDA notice announces a draft guidance on Master Files for new dietary ingredient notifications in dietary supplements. Master Files are voluntary, not required by statute or regulation. The notice is not a final rule and does not determine compliance or current law. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The FDA announced availability of a draft guidance on Master Files for new dietary ingredient notifications. [1]

  2. The draft guidance, when finalized, would recommend how industry submits and uses Master Files containing identity, manufacturing or safety data. [1]

  3. Master Files are submitted at the owner's discretion and are not required by statute or regulation. [1]

The source at a glance

Jurisdiction
US
Authority
Health and Human Services Department; Food and Drug Administration
Document type
Notice
Record type / format
Notice (Federal Register document record)
Scope / context
Dietary supplement industry in the United States; Master File owners, as described in the agency abstract.
Summary based on
Official regulatory document
Original publication
April 4, 2024

US FDA notice on draft guidance for supplement Master Files

This is a notice from the US Department of Health and Human Services and the Food and Drug Administration, published on 4 April 2024. It announces the availability of a draft guidance for industry titled "New Dietary Ingredient Notification Master Files for Dietary Supplements." The draft guidance, when finalized, is meant to give recommendations to the dietary supplement industry on Master Files for new dietary ingredients. The stated purpose is to help industry comply more easily with the new dietary ingredient notification requirement.

Supporting source [1]

Voluntary Master Files with identity, manufacturing or safety data

According to the agency abstract, the draft guidance would provide recommendations on the submission and use of Master Files. Such files contain identity, manufacturing or safety data that can be used to support a new dietary ingredient notification. The abstract states that new dietary ingredient Master Files are submitted solely at the discretion of the Master File owner and are not required by statute or regulation.

Supporting source [1]

Draft status, informational rendition and date caveats

The document is a notice, not a final rule, and a publication date is not necessarily an effective date. The web rendition is an informational resource, not the official legal edition; the linked official PDF on GovInfo should be verified along with later amendments. This source alone does not determine a product's compliance or current legal status.

Supporting source [1]

How to interpret this

Document summary; not a determination of current law. Based on the agency abstract and metadata, not the full document. A notice is not a final rule; publication date is not necessarily an effective date. The web rendition is informational; verify the official PDF and later amendments.

Based on the cited official document. Its jurisdiction, document type and effective date matter; a proposal or notice is not a rule already in force.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    announcing the availability of a draft guidance
  2. Finding 2 ↑

    recommendations on the submission and use of
  3. Finding 3 ↑

    not required by statute or regulation

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…